Imagen de Portada

Comparing two hazard curves when there is a treatment time‐lag effect

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Xiaoxi Zhang, Somnath Datta, Peihua Qiu
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Statistics in Medicine
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Multiblock partial least squares and rank aggregation: Applications to detection of bacteriophages associated with antimicrobial resistance in the presence of potential confounding factors
por: Shoumi Sarkar, et al.
Publicado: (2024)

Integrating Multiple Clustering Techniques and Performance Measures via Ranking for scRNA‐Seq Data
por: Owen Visser, et al.
Publicado: (2025)

Generalized single index modeling of longitudinal data with multiple binary responses
por: Zibo Tian, et al.
Publicado: (2024)

Can the Unit Size Predict Outcomes? Testing for Informativeness in Three‐Level Designs
por: Samuel Anyaso‐Samuel, et al.
Publicado: (2025)

Propensity score matching for estimating a marginal hazard ratio
por: Tongrong Wang, et al.
Publicado: (2024)

Sample size calculation for comparing two screening tests when the gold standard is missing at random
por: Yougui Wu
Publicado: (2024)

Conditional-Marginal Nonparametric Estimation for Stage Waiting Times from Multi-Stage Models under Dependent Right Censoring
por: Zhang, Xiaoxi, et al.
Publicado: (2025)

Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
por: Matthias Kormaksson, et al.
Publicado: (2024)

Assurance methods for designing a clinical trial with a delayed treatment effect
por: James A. Salsbury, et al.
Publicado: (2024)

Finding the best subgroup with differential treatment effect with multiple outcomes
por: Beibo Zhao, et al.
Publicado: (2024)

Validation of predicted individual treatment effects in out of sample respondents
por: Alena Kuhlemeier, et al.
Publicado: (2024)

Survival causal rule ensemble method considering the main effect for estimating heterogeneous treatment effects
por: Ke Wan, et al.
Publicado: (2024)

Confidence distributions for treatment effects in clinical trials: Posteriors without priors
por: Ian C. Marschner
Publicado: (2024)

A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
por: Stephen Schüürhuis, et al.
Publicado: (2024)

Collaborative inference for treatment effect with distributed data‐sharing management in multicenter studies
por: Mengtong Hu, et al.
Publicado: (2024)

Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects
por: Carly Lupton Brantner, et al.
Publicado: (2024)

Group sequential designs for clinical trials when the maximum sample size is uncertain
por: Amin Yarahmadi, et al.
Publicado: (2024)

A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
por: Tianyu Zhan
Publicado: (2024)

Targeted learning in observational studies with multi‐valued treatments: An evaluation of antipsychotic drug treatment safety
por: Jason Poulos, et al.
Publicado: (2024)

Sample size determination for prediction models via learning‐type curves
por: Alimu Dayimu, et al.
Publicado: (2024)

Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
por: Edward L. Korn, et al.
Publicado: (2024)

Comparing Methods to Assess Treatment Effect Heterogeneity in General Parametric Regression Models
por: Yao Chen, et al.
Publicado: (2026)

Beyond the two‐trials rule
por: Leonhard Held
Publicado: (2024)

Enhancing long‐term survival prediction with two short‐term events: Landmarking with a flexible varying coefficient model
por: Wen Li, et al.
Publicado: (2024)

Comparing methods for assessing the reliability of health care quality measures
por: Kenneth J. Nieser, et al.
Publicado: (2024)

A Biomarker‐Based Dose–Schedule Optimization Design for Immunotherapy Trials
por: Yingjie Qiu, et al.
Publicado: (2026)

Adding experimental treatment arms to multi‐arm multi‐stage platform trials in progress
por: Thomas Burnett, et al.
Publicado: (2024)

An Information Criterion Approach for Assessing Agreement When Comparing Two Methods of Measurement
por: Charles Y. Tan, et al.
Publicado: (2025)

Separable and controlled direct effects for competing events: Estimation of component specific effects on sickness absence
por: Niklas N. Maltzahn, et al.
Publicado: (2024)

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
por: Jonathan C. Moyer, et al.
Publicado: (2024)

A Unified Framework for Statistical Inference and Power Analysis of Single and Comparative Fβ Scores
por: Chih‐Yuan Hsu, et al.
Publicado: (2026)

Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
por: Wenhao Cao, et al.
Publicado: (2024)

A latent variable approach to jointly modeling longitudinal and cumulative event data using a weighted two‐stage method
por: Madeline R. Abbott, et al.
Publicado: (2024)

Statistical inference on qualitative differences in the magnitude of an effect
por: Aaron Hudson, et al.
Publicado: (2024)

Bayesian Power Prior in Platform Trials With Non‐Concurrent Control for Binary Outcomes: Development and Comparative Evaluation
por: Junichi Asano, et al.
Publicado: (2026)

Modeling variation in mixture effects over space with a Bayesian spatially varying mixture model
por: Joseph Boyle, et al.
Publicado: (2024)

Multiple imputation strategies for missing event times in a multi‐state model analysis
por: Elinor Curnow, et al.
Publicado: (2024)

Identification and estimation of causal effects in the presence of confounded principal strata
por: Shanshan Luo, et al.
Publicado: (2024)

BHAFT: Bayesian heredity‐constrained accelerated failure time models for detecting gene‐environment interactions in survival analysis
por: Na Sun, et al.
Publicado: (2024)

Bridging the gap between two‐stage and joint models: The case of tumor growth inhibition and overall survival models
por: Danilo Alvares, et al.
Publicado: (2024)